IN BRIEF: BSF Enterprise hails milestones, eyes spin-out potential

Tue, 26th May 2026 14:43

BSF Enterprise PLC - London-based biotech company - Summarises recent "key milestones" for its subsidiaries. Lab-Grown Leather Ltd has unveiled its "T-rex leather" handbag, made from synthetic dinosaur DNA, with a bag scheduled for auction on June 11 in Paris. Kerato Ltd, which targets the corneal transplant market, has begun phase-one veterinary trials funded by the Canadian government, and aims to sign distribution deals in the fourth quarter of 2026. Applications for human trials are planned between 2026 and 2027. For both Lab-Grown Leather and Kerato, BSF "is evaluating potential subsidiary-level financing options, including possible spin-out structures, which may enable future growth capital to be raised at subsidiary level". Its other subsidiary, 3D Bio-Tissues Ltd, has launched its CytoBoost Revive product, with a commercial pipeline estimated at GBP500,000 and new partnerships planned in the second and third quarters. The company adds that 2026 is "a critical time for BSF and its shareholders" as its subsidiaries move from research and development into commercialisation.

Current share price: 1.90 pence, up 22% on Tuesday afternoon in London

12-month change: down 8.8%

By Holly Munks, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Corporate News Finance and Instruments Funds

Bio-Sustainable Future Enterprises